AB
Abbvie
ABBV13F as of Jun 30, 2026 · next update ~Nov 14
Who's buying ABBV
Top funds mostly trimmed Abbvie in Q2 (Apr–Jun)
Buying:
FundsInsidersCongress
- Top funds0 of 7 bought more, 5 sold some. Largest: Torray Investment Partners, $20.8M (3% of its portfolio).
- InsidersNo buys, 4 sales in 12 months.
- CongressNo buys, 4 sales in 12 months.
7 funds$50.0M held0.6% avg. weightQ2: 0 bought / 5 sold
13F reports are a snapshot as of Jun 30, 2026; funds may have traded since. Insiders often sell for personal reasons (taxes, diversification, planned sales).
Share price · market data, not from 13F reports
Q2 2026